4503

COM:ASTELLAS

Astellas Pharma Inc.

  • Stock

JPY

Last Close

1,562.00

25/11 06:45

Market Cap

2.98T

Beta: -

Volume Today

14.54M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
120.58B
-
146.07B
21.13%
159.30B
9.06%
172.11B
8.04%
165.08B
4.09%
149.57B
9.40%
151.26B
1.13%
157.55B
4.15%
158.58B
0.65%
163.73B
3.25%
211.56B
29.21%
average payables
144.93B
-
206.82B
42.70%
204.08B
1.32%
182.19B
10.73%
161.87B
11.16%
163.09B
0.76%
178.62B
9.52%
148.37B
16.94%
127.76B
13.89%
135.49B
6.05%
162.71B
20.10%
average receivables
343.51B
-
339.60B
1.14%
342.09B
0.73%
332.50B
2.80%
329.55B
0.89%
352.59B
6.99%
368.74B
4.58%
363.88B
1.32%
380.58B
4.59%
425.26B
11.74%
497.28B
16.93%
book value per share
564.64
-
596.59
5.66%
583.47
2.20%
603.00
3.35%
624.71
3.60%
651.38
4.27%
687.12
5.49%
746.38
8.62%
789.48
5.77%
828.54
4.95%
889.98
7.42%
capex per share
-24.99
-
-36.74
47.01%
-54.73
48.96%
-23.07
57.86%
-19.84
13.97%
-26.98
35.98%
-41.51
53.85%
-41.70
0.45%
-41.33
0.89%
-48.65
17.71%
-46.00
5.44%
capex to depreciation
-0.87
-
-1.24
41.98%
-1.71
37.71%
-0.76
55.33%
-0.62
18.56%
-0.82
32.26%
-1.17
42.81%
-1.07
9.14%
-0.96
9.99%
-0.84
12.72%
-0.52
37.58%
capex to operating cash flow
-0.26
-
-0.43
65.03%
-0.38
12.94%
-0.21
45.16%
-0.13
37.59%
-0.20
56.41%
-0.35
74.07%
-0.25
28.07%
-0.30
17.66%
-0.27
9.03%
-0.45
68.42%
capex to revenue
-0.05
-
-0.07
32.12%
-0.09
32.23%
-0.04
56.90%
-0.03
16.47%
-0.04
28.80%
-0.06
50.05%
-0.06
3.51%
-0.06
4.83%
-0.06
1.15%
-0.05
11.77%
cash per share
189.97
-
206.57
8.74%
173.49
16.01%
168.07
3.13%
170.06
1.18%
162.37
4.52%
174.74
7.62%
178.60
2.21%
182.34
2.09%
217.92
19.51%
187.19
14.10%
days of inventory on hand
149.29
-
171.88
15.14%
175.86
2.31%
207.88
18.21%
183.12
11.91%
189.36
3.40%
199.18
5.19%
243.39
22.20%
220.83
9.27%
220.74
0.04%
232.02
5.11%
days payables outstanding
206.48
-
248.23
20.22%
197.47
20.45%
208.21
5.44%
174.79
16.05%
231.56
32.48%
226.80
2.06%
185.09
18.39%
188.61
1.90%
177.51
5.88%
172.74
2.69%
days sales outstanding
108.62
-
99.49
8.40%
91.52
8.01%
89.27
2.46%
94.96
6.37%
102.51
7.95%
103.99
1.44%
104.33
0.33%
113.77
9.04%
107.32
5.67%
124.73
16.23%
debt to assets
0.26
-
debt to equity
0.58
-
dividend yield
0.02
-
0.01
32.97%
0.02
50.75%
0.02
5.21%
0.02
3.60%
0.02
0.85%
0.02
6.39%
0.02
2.72%
0.02
0.08%
0.03
21.44%
0.04
35.37%
earnings yield
0.03
-
0.03
5.42%
0.06
91.86%
0.07
17.94%
0.05
28.95%
0.07
35.30%
0.06
8.33%
0.04
38.79%
0.04
7.99%
0.03
17.95%
0.01
79.89%
enterprise value
2.36T
-
3.95T
67.49%
2.87T
27.35%
2.75T
4.13%
2.95T
7.05%
2.96T
0.43%
2.82T
4.77%
2.83T
0.64%
3.22T
13.55%
3.05T
5.24%
3.53T
15.63%
enterprise value over ebitda
12.55
-
15.30
21.89%
8.63
43.59%
7.92
8.25%
10.34
30.65%
9.43
8.84%
8.95
5.07%
12.87
43.78%
14.81
15.13%
12.37
16.52%
10.50
15.09%
ev to operating cash flow
11.01
-
21.05
91.20%
9.15
56.54%
11.68
27.66%
9.42
19.32%
11.44
21.39%
12.69
10.95%
9.24
27.19%
12.50
35.34%
9.31
25.57%
19.45
109.02%
ev to sales
2.07
-
3.17
53.07%
2.09
33.99%
2.10
0.33%
2.26
7.98%
2.26
0.03%
2.17
4.36%
2.27
4.77%
2.48
9.47%
2.01
19.12%
2.20
9.50%
free cash flow per share
70.38
-
48.22
31.49%
90.64
87.98%
88.64
2.21%
134.14
51.32%
106.89
20.31%
76.81
28.14%
123.53
60.82%
97.85
20.78%
131.44
34.33%
55.11
58.07%
free cash flow yield
0.06
-
0.02
57.38%
0.06
147.15%
0.06
0.17%
0.08
37.45%
0.06
23.99%
0.05
27.24%
0.07
57.89%
0.05
29.45%
0.07
36.33%
0.03
51.89%
graham net net
162.11
-
142.19
12.28%
80.30
43.53%
65.08
18.96%
40.82
37.28%
13.12
67.85%
-185.31
1,512.22%
-110.88
40.17%
-83.94
24.29%
-71.35
15.00%
-614.81
761.68%
graham number
716.88
-
908.58
26.74%
1.09K
19.47%
1.19K
9.27%
1.07K
9.98%
1.30K
21.61%
1.27K
2.28%
1.04K
17.71%
1.09K
4.54%
1.01K
7.89%
436.27
56.61%
income quality
1.76
-
0.99
43.67%
1.20
21.13%
0.84
30.23%
1.43
71.40%
1.04
27.52%
0.90
12.90%
2.11
133.35%
1.64
22.28%
2.48
50.91%
10.64
329.59%
intangibles to total assets
0.24
-
0.24
0.36%
0.27
12.98%
0.31
13.52%
0.34
9.68%
0.35
1.91%
0.43
25.62%
0.41
5.19%
0.40
3.46%
0.36
8.70%
0.12
67.66%
interest coverage
70.45
-
60.32
14.38%
153.03
153.71%
132.00
13.75%
119.67
9.34%
187.34
56.54%
81.22
56.64%
58.27
28.26%
31.46
46.01%
15.15
51.83%
14.83
2.11%
interest debt per share
0.74
-
1.39
88.79%
0.75
45.89%
0.94
24.27%
0.88
6.31%
0.67
23.22%
1.60
137.57%
1.26
21.47%
2.68
112.80%
4.82
80.28%
519.73
10,674.81%
inventory turnover
2.44
-
2.12
13.15%
2.08
2.26%
1.76
15.40%
1.99
13.52%
1.93
3.29%
1.83
4.93%
1.50
18.16%
1.65
10.22%
1.65
0.04%
1.57
4.86%
invested capital
0.58
-
market cap
2.75T
-
4.35T
58.07%
3.23T
25.69%
3.09T
4.26%
3.28T
5.97%
3.27T
0.24%
3.14T
4.09%
3.16T
0.82%
3.53T
11.83%
3.43T
3.05%
2.94T
14.13%
net current asset value
528.66B
-
490.30B
7.26%
357.41B
27.10%
327.57B
8.35%
255.70B
21.94%
217.91B
14.78%
-161.48B
174.10%
-14.93B
90.76%
51.27B
443.50%
101.39B
97.77%
-778.88B
868.21%
net debt to ebitda
-2.08
-
-1.54
26.28%
-1.08
29.48%
-0.98
9.38%
-1.16
18.76%
-0.99
14.89%
-1.01
2.02%
-1.48
46.34%
-1.45
1.76%
-1.53
5.05%
1.74
213.86%
net income per share
40.45
-
61.50
52.03%
89.75
45.93%
103.69
15.54%
81.11
21.77%
115.05
41.84%
104.15
9.47%
64.93
37.66%
67.08
3.31%
54.24
19.15%
9.50
82.48%
operating cash flow per share
95.37
-
84.96
10.92%
145.37
71.11%
111.71
23.16%
153.98
37.84%
133.87
13.06%
118.32
11.62%
165.22
39.64%
139.18
15.76%
180.09
29.39%
101.11
43.85%
payables turnover
1.77
-
1.47
16.82%
1.85
25.71%
1.75
5.16%
2.09
19.12%
1.58
24.52%
1.61
2.10%
1.97
22.53%
1.94
1.87%
2.06
6.25%
2.11
2.76%
receivables turnover
3.36
-
3.67
9.17%
3.99
8.71%
4.09
2.52%
3.84
5.99%
3.56
7.36%
3.51
1.42%
3.50
0.33%
3.21
8.29%
3.40
6.01%
2.93
13.96%
research and ddevelopement to revenue
0.17
-
0.17
1.38%
0.16
0.75%
0.16
3.48%
0.17
7.00%
0.16
5.92%
0.17
7.90%
0.18
4.23%
0.19
5.64%
0.18
4.20%
0.18
0.89%
return on tangible assets
0.07
-
0.10
37.95%
0.15
48.22%
0.17
17.52%
0.13
22.87%
0.18
33.47%
0.15
16.78%
0.09
39.49%
0.09
2.06%
0.06
28.56%
0.01
91.42%
revenue per share
507.41
-
564.61
11.27%
636.06
12.66%
621.89
2.23%
640.49
2.99%
676.20
5.58%
693.34
2.53%
672.83
2.96%
700.74
4.15%
834.40
19.07%
894.27
7.18%
roe
0.07
-
0.10
43.89%
0.15
49.21%
0.17
11.80%
0.13
24.49%
0.18
36.03%
0.15
14.18%
0.09
42.61%
0.08
2.33%
0.07
22.96%
0.01
83.69%
roic
0.07
-
0.10
47.07%
0.15
45.00%
0.16
8.80%
0.13
20.25%
0.17
36.30%
0.15
12.89%
0.08
45.97%
0.08
3.53%
0.07
21.98%
0.05
22.73%
sales general and administrative to revenue
0.35
-
0.36
4.17%
0.36
0.47%
0.36
1.53%
0.37
2.49%
0.38
2.02%
0.38
2.27%
0.40
5.15%
0.42
4.91%
0.42
1.98%
shareholders equity per share
564.64
-
596.59
5.66%
583.47
2.20%
603.00
3.35%
624.71
3.60%
651.38
4.27%
687.12
5.49%
746.38
8.62%
789.48
5.77%
828.54
4.95%
889.98
7.42%
stock based compensation to revenue
tangible asset value
871.59B
-
885.74B
1.62%
769.35B
13.14%
709.04B
7.84%
638.40B
9.96%
602.83B
5.57%
283.15B
53.03%
450.68B
59.16%
533.85B
18.45%
617.05B
15.58%
1.18T
90.79%
tangible book value per share
387.98
-
400.95
3.34%
356.49
11.09%
336.17
5.70%
314.45
6.46%
312.04
0.77%
150.92
51.64%
242.67
60.80%
288.61
18.93%
339.03
17.47%
656.50
93.64%
working capital
572.60B
-
545.07B
4.81%
484.18B
11.17%
476.81B
1.52%
424.00B
11.08%
359.49B
15.21%
68.81B
80.86%
280.22B
307.26%
235.94B
15.80%
323.92B
37.29%
-91.00B
128.09%

All numbers in JPY (except ratios and percentages)